OpenURL Connection Search

Select item for more details and to access through your institution.

Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions.
Published in:
Cytopathology, 2008, v. 19, n. 4, p. 205, doi. 10.1111/j.1365-2303.2007.00468.x
By:
- Metzgeroth, G.;
- Kuhn, C.;
- Schultheis, B.;
- Hehlmann, R.;
- Hastka, J.
Publication type:
Article
Stable RNA interference (RNAi) as an option for anti-bcr-abl therapy.
Published in:
Gene Therapy, 2005, v. 12, n. 1, p. 12, doi. 10.1038/sj.gt.3302328
By:
- Scherr, M;
- Battmer, K;
- Schultheis, B;
- Ganser, A;
- Eder, M
Publication type:
Article
Intestinal-type adenocarcinoma situated in the nasopharynx.
Published in:
Cytopathology, 2007, v. 18, n. 1, p. 59, doi. 10.1111/j.1365-2303.2006.00357.x
By:
- Metzgeroth, G.;
- Back, W.;
- Schultheis, B.;
- Maywald, O.;
- Kuhn, C.;
- Hehlmann, R.;
- Hastka, J.
Publication type:
Article
Alterations of the cyclin D1/pRb/p16[supINK4A] pathway in multiple myeloma.
Published in:
Leukemia (08876924), 2002, v. 16, n. 9, p. 1844
By:
- Kramer, A.;
- Schultheis, B.;
- Bermann, J.;
- Willer, A.;
- Hegenbart, U.;
- Ho, A.D.;
- Goldschmidt, H.;
- Hehlmann, R.
Publication type:
Article
Analysis of p73 and p53 gene deletions in multiple myeloma.
Published in:
1999
By:
- Schultheis, B;
- Krämer, A;
- Willer, A;
- Hegenbart, U;
- Goldschmidt, H;
- Hehlmann, R
Publication type:
journal article
Does long-term culture favor normal clonogenic cells from interferon-treated patients with chronic myelogenous leukemia?
Published in:
1999
By:
- Pasternak, G.;
- Schultheis, B.;
- Heissig, B.;
- Hömer, S.;
- Sick, C.;
- Hehlmann, R.;
- Hörner, S
Publication type:
journal article
Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study.
Published in:
British Journal of Cancer, 2012, v. 106, n. 11, p. 1722, doi. 10.1038/bjc.2012.153
By:
- Strumberg, D;
- Scheulen, M E;
- Schultheis, B;
- Richly, H;
- Frost, A;
- Büchert, M;
- Christensen, O;
- Jeffers, M;
- Heinig, R;
- Boix, O;
- Mross, K
Publication type:
Article
Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours.
Published in:
2008
By:
- Strumberg, D;
- Schultheis, B;
- Adamietz, I A;
- Christensen, O;
- Buechert, M;
- Kraetzschmar, J;
- Rajagopalan, P;
- Ludwig, M;
- Frost, A;
- Steinbild, S;
- Scheulen, M E;
- Mross, K
Publication type:
journal article
Predominantly BCR-ABL negative myeloid precursors in interferon-α treated chronic myelogenous leukemia: a follow-up study of peripheral blood colony-forming cells with fluorescence in situ hybridization.
Published in:
Annals of Hematology, 2001, v. 80, n. 1, p. 9, doi. 10.1007/s002770000237
By:
- Sick, C.;
- Schultheis, B.;
- Pasternak, G.;
- Kottke, I.;
- Hörner, S.;
- Heissig, B.;
- Hehlmann, R.
Publication type:
Article
Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors.
Published in:
2012
By:
- Schultheis B;
- Kummer G;
- Zeth M;
- Brendel E;
- Xia C;
- Kornacker M;
- Strumberg D
Publication type:
Journal Article
Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 333, doi. 10.1007/s00280-011-1685-x
By:
- Schultheis, B.;
- Kummer, G.;
- Zeth, M.;
- Brendel, E.;
- Xia, C.;
- Kornacker, M.;
- Strumberg, D.
Publication type:
Article
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG.
Published in:
Leukemia (08876924), 2009, v. 23, n. 12, p. 2248, doi. 10.1038/leu.2009.183
By:
- Lengfelder, E.;
- Haferlach, C.;
- Saussele, S.;
- Haferlach, T.;
- Schultheis, B.;
- Schnittger, S.;
- Ludwig, W.-D.;
- Staib, P.;
- Aul, C.;
- Grüneisen, A.;
- Kern, W.;
- Reichle, A.;
- Serve, H.;
- Berdel, W. E.;
- Braess, J.;
- Spiekermann, K.;
- Wörmann, B.;
- Sauerland, M.-C.;
- Heinecke, A.;
- Hiddemann, W.
Publication type:
Article
Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1/CSF1R signaling abnormalities in the cell line GDM1.
Published in:
Leukemia (08876924), 2009, v. 23, n. 2, p. 358, doi. 10.1038/leu.2008.295
By:
- Chase, A.;
- Schultheis, B.;
- Kreil, S.;
- Baxter, J.;
- Hidalgo-Curtis, C.;
- Jones, A.;
- Zhang, L.;
- Grand, F. H.;
- Melo, J. V.;
- Cross, N. C. P.
Publication type:
Article
Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL – Inhibition of P-glycoprotein function by 17-AAG.
Published in:
Leukemia (08876924), 2005, v. 19, n. 7, p. 1198, doi. 10.1038/sj.leu.2403764
By:
- Radujkovic, A.;
- Schad, M.;
- Topaly, J.;
- Veldwijk, M. R.;
- Laufs, S.;
- Schultheis, B. S.;
- Jauch, A.;
- Melo, J. V.;
- Fruehauf, S.;
- Zeller, W. J.
Publication type:
Article
e8a2 BCR-ABL: more frequent than other atypical BCR-ABL variants?
Published in:
2005
By:
- Demehri, S.;
- Paschka, P.;
- Schultheis, B.;
- Lange, T.;
- Koizumi, T.;
- Sugimoto, T.;
- Branford, S.;
- Lim, L.-C.;
- Kegel, T.;
- Martinelli, G.;
- Hochhaus, A.;
- Druker, B. J.;
- Deininger, M. W. N.
Publication type:
Letter
BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis.
Published in:
Leukemia (08876924), 2003, v. 17, n. 10, p. 2054, doi. 10.1038/sj.leu.2403079
By:
- Schultheis, B.;
- L. Wang;
- Clark, R.E.;
- Melo, J.V.
Publication type:
Article
Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial.
Published in:
2007
By:
- Ernst, T.;
- Merx, K.;
- Gnad-Vogt, U.;
- Lukan, N.;
- Kripp, M;
- Schultheis, B.;
- Hochhaus, A.;
- Hofheinz, R.-D.
Publication type:
journal article

Found: 17